This article is part of the supplement: B cells in autoimmune diseases: Part 1

Review

Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity

Henrik E Mei*, Stefanie Schmidt and Thomas Dörner

Arthritis Research & Therapy 2012, 14(Suppl 5):S1 doi:10.1186/ar3909

Accesses  

  • Last 30 days: 332 accesses
  • Last 365 days: 2474 accesses
  • All time: 2474 accesses

Cited by

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations